Viewing StudyNCT03944356



Ignite Creation Date: 2024-05-06 @ 1:09 PM
Last Modification Date: 2024-10-26 @ 1:09 PM
Study NCT ID: NCT03944356
Status: UNKNOWN
Last Update Posted: 2022-08-26
First Post: 2019-04-26

Brief Title: BRAF-MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Sponsor: EuMelaReg gGmbH
Organization: EuMelaReg gGmbH

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords: